Literature DB >> 8572249

Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells.

M A Fiedler1, K Wernke-Dollries, J M Stark.   

Abstract

The mechanism of respiratory syncytial virus (RSV)-induced inflammation in the airways of infants and children is not fully understood. We hypothesized that RSV directly induces interleukin (IL)-8 gene expression in airway epithelial cells, independent of IL-1 beta and tumor necrosis factor-alpha (TNF-alpha) production. Exposure of A549 cells (an airway epithelial cell line) to RSV resulted in increased IL-8 mRNA expression and IL-8 protein release from the cells as early as 2 h after treatment. Neither IL-1 beta nor TNF-alpha (mRNA or protein) were detected. Viral replication was not necessary for the effects of RSV on IL-8 mRNA expression and protein release early in the infectious process. However, sustained levels of increased IL-8 production required RSV replication. A dose-response relationship was observed between the multiplicity of infection and IL-8 production with both active and nonreplicative RSV at the 2-h time point. Both active RSV and nonreplicative RSV increased the transcriptional activity of the 1.6-kb 5' flanking region of the IL-8 gene. Neither active RSV nor nonreplicative RSV increased the stability of the IL-8 mRNA in A549 cells. We conclude that RSV increases IL-8 gene expression in A549 cells in a biphasic pattern independent of viral replication early (2 h) but dependent on viral replication late (24 h).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8572249     DOI: 10.1152/ajplung.1995.269.6.L865

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  32 in total

1.  A role for the alveolar epithelium in recruitment of mononuclear cells into the lung.

Authors:  D M Center
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

2.  Scavenger receptor SREC-I promotes double stranded RNA-mediated TLR3 activation in human monocytes.

Authors:  Ayesha Murshid; Jianlin Gong; Ridwan Ahmad; Thiago J Borges; Stuart K Calderwood
Journal:  Immunobiology       Date:  2014-12-30       Impact factor: 3.144

3.  Alveolar epithelial cell chemokine expression triggered by antigen-specific cytolytic CD8(+) T cell recognition.

Authors:  M Q Zhao; M H Stoler; A N Liu; B Wei; C Soguero; Y S Hahn; R I Enelow
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

4.  Autocrine regulation of interleukin-8 by interleukin-1alpha in respiratory syncytial virus-infected pulmonary epithelial cells in vitro.

Authors:  J A Patel; Z Jiang; N Nakajima; M Kunimoto
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

5.  Respiratory syncytial virus influences NF-kappaB-dependent gene expression through a novel pathway involving MAP3K14/NIK expression and nuclear complex formation with NF-kappaB2.

Authors:  Sanjeev Choudhary; Steve Boldogh; Roberto Garofalo; Mohammad Jamaluddin; Allan R Brasier
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 6.  Eosinophils, ribonucleases and host defense: solving the puzzle.

Authors:  H F Rosenberg; J B Domachowske
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

Review 7.  The immune response to respiratory syncytial virus infection: friend or foe?

Authors:  Robert C Welliver
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

8.  Interaction of alveolar epithelial cells with CFP21, a mycobacterial cutinase-like enzyme.

Authors:  Pooja Vir; Dheeraj Gupta; Ritesh Agarwal; Indu Verma
Journal:  Mol Cell Biochem       Date:  2014-08-05       Impact factor: 3.396

Review 9.  Association of rhinovirus infections with asthma.

Authors:  J E Gern; W W Busse
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

Review 10.  Epidemiologic, experimental, and clinical links between respiratory syncytial virus infection and asthma.

Authors:  Shyam S Mohapatra; Sandhya Boyapalle
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.